LGALS3 and atrial fibrillation: GAL3 emerged as a robust biomarker in AF, as elevated levels have been strongly correlated with AF development, while GAL3 levels were found to be higher among patients with persistent AF, underlining the importance of this biomarker in the maintenance of the arrhythmia [28,29].